附件3.1。

VENTYX BIOSCIENCES, INC.

偏好、权利和限制的指定证书

的

A系列 非表决 可转换优先股

根据第151条

下方签署的Paul A.Friedman博士特此证明：

VENTYX BIOSCIENCES, INC.根据特拉华州公司法第103条的规定，特此证明，以下董事会在2019年4月4日依照特拉华州公司法的第141条(c)和第151条的规定，正式通过以下决议: "，一个特拉华州的公司（以下简称“公司”）公司根据特拉华州公司法第103条的规定，根据（特拉华州公司法）特此证明，根据DGCL第151条的规定，公司董事会已经通过了以下决议（董事会本提案自本日期起继续完全有效：

已解决依据公司修订后的公司章程中明确规定的权限 “公司章程公司已获授权发行一系列指定为A系列的优先股 无表决权的股份 可转换优先股，每股面值为$0.0001，特此授权公司，并确定了该系列的指定股数、权力、首选权、权利、条件、限制以及限制（除公司章程中适用于优先股的任何规定外），并确定了Series A的优先权偏好、权利和限制的指定书 无表决权的股份 可转换优先股如下获得批准:

A系列 无表决权 可转换优先股

第 1. 定义为了本文件的目的，以下术语应具有以下含义:

“附属公司“”指任何直接或间接通过一个或多个中介控制或被控制或与个人或实体共同控制的个人或实体，如根据美国1933年证券法修正案第144条下使用和解释的术语所述。

“第十章 转让证券 第10.1节 交易 如果发行受托人证明，债券持有人可以交换并迅速交付发行受托人这样的证明，无论是有欠款未偿还，还是实质性周转的时候，都可以在世界范围范围内经由源和债券市场交易。“”指除星期六、星期日、美国联邦法定假日或纽约州授权或法律或其他政府行为要求银行机构关闭的任何一天。

“委员会:“”指美国证券交易委员会。

“普通股“”指公司普通股，每股面值$0.0001，以及这些证券未来可能被重新分类为的任何其他类别的股票。

“转换日期“”指转换为A系列优先股的日期 第 6.

“转换 价格“”指A系列优先股的价格为每股$1.00，如有股息、股票分割、合并或其他类似资本重组，应适当调整。

“Conversion Shares“”指根据本协议条款转换为普通股的股份。

“被视为清算事件“”指： （i）公司或其子公司出售、租赁、转让、独家许可或其他处置（无论是合并还是其他方式）集团公司全部或几乎全部资产的（或任何相关交易系列导致的全部或几乎全部资产的出售、租赁、转让、独家许可或其他处置）；（ii）核心子公司的清算、解散、清算或类似程序；（iii）集团公司全部或几乎全部知识产权的出售、转让或其他处置或独家许可（或任何相关交易系列导致集团公司全部或几乎全部知识产权的出售、转让或其他处置或独家许可）；（iv）公司或任何核心子公司及其发行的优先权股本的大多数或多数表决权的出售、转让、交易或其他处置，或要求出售、转让或其他处置公司或任何核心子公司及其发行的优先权股票的大多数或多数表决权的独家许可；（v）公司或任何核心子公司并入任何其他企业的合并、合并、合并或其他业务组合，或任何其他公司重组或安排，情况如下：（1）公司或此类任何核心子公司在此类交易之前拥有已发行的股本票据的50%的股东（对于任何作为国内公司的核心子公司，实际控制人是WFOE I或WFOE II(适用的)）在此类交易之后立即拥有少于所有已发行和流通股份的表决权的50%；或者（2）在公司采用双重投票结构之前，导致创始人参与方（连同其关联公司和与创始人参与方共同行动的人，如有的话）共同拥有公司发行和流通的所有权益证券的表决权，直接或间接持有创始人参与方（连同与创始人参与方共同行动的人，如有的话）共同拥有的所有流通证券的表决权少于交易后存续企业的所有发行和流通权益证券的表决权的50%；或（vi）在未经系列A多数、系列b多数、系列C多数、系列D多数和系列E多数的书面同意的情况下，任何集团公司之间对于旨在为公司提供对控制实体的控制和合并能力的合同之间的（包括但不仅限于终止（根据法律或其他方式）、重大违约或修改）的任何违规行为，均以尽力避免为所有集团公司维护其合规性和有效性，并且包括终止（因法律或其他方式）、重大违约或更改合作协议内代表A多数、系列B多数、系列C多数、系列D多数和系列E多数的解约（依据法律或其他方式）。解约或重大修改。不影响上述情况的是，创始人参与方（包括其关联方和与创始人参与方共同行动的人，如有的话）拥有公司投票权的总表决权少于50%不构成或被视为极限清算事件。“”指：(a)涉及合并或合并事项，其中(i)公司是合并方之一或(ii)公司的子公司是合并方之一且公司根据该合并或合并交易发行其股票；但不包括公司或子公司涉及的任何合并或合并事项，根据这类合并或合并事项，公司在合并或合并前，公司的流通股份继续代表，或转换为或交换成代表，在合并或合并后立即最少具有相当多数表决权的资本股份，在(1)生存的或产生的公司，或(2)如果生存的或产生的公司是另一公司的全资子公司，则为合并或合并后立即该生存的或产生的公司的母公司；或（b）出售、出租、转让、独家许可或其他

 

1

在一笔交易或一系列相关交易中，公司或公司的任何子公司对公司及其全部或几乎全部资产的转让，或公司的一个或多个子公司的出售或转让（无论通过合并、合并或其他方式），如果公司及其全部子公司的几乎全部资产 被此类子公司或子公司持有，除非此类销售、租赁、转让、排他性许可或其他处置是向公司的全资子公司。

“特拉华州公司法” 意指特拉华州一般公司法。

“使拥有公司注册证券类别10%以上股权的官员、董事或实际股东代表签署人递交表格3、4和5（包括修正版及有关联合递交协议）,符合证券交易法案第16(a)条及其下属规则规定的要求；” 意指美国1934年修订版《证券交易法》及其制定的规则和法规。

“持有人” 意指A类优先股的任何持有人。

“发行日期“” 表示2024年9月23日。

“清算“”在第5.21(a)条中有所规定 第 5.

“持有“” 表示任何个人或公司、合伙企业、信托、有限责任公司、合资公司、有限责任合伙公司、股份有限公司、政府（或其机构或下属单位）、或任何其他形式的实体。

“证券购买协议(以下简称“协议”)“” 表示定于2024年9月23日生效的关于购买和出售A类优先股的某项证券购买协议，该协议由公司与Aventis Inc.之间达成。

“Series A优先股“”在第5.21(a)条中有所规定 第蘋果CEO庫克大规模售不可认购投票股票，套现超3亿港元。.

“分享转换 数字“”在第5.21(a)条中有所规定 第6(a).

“签署日期“”表示证券购买协议的生效日期。

“定价“”表示每股100.00美元。

“标准结算期“”指转换日期有效的公司主要交易市场或报价系统有关普通股的标准结算期，以交易日数表示，截至发行日期是“T+1”。

“交易日“”表示普通股在任何交易所交易的日期，或者如果普通股未在主要证券交易所交易，则指普通股在其他正在交易的证券市场上交易的日期。

第 2. 职位、金额和面值；分配；排名.

(a) 本特许证书指定的优先股系列的独特序列标识应被指定为公司的A系列 无表决权的股份 可转换优先股（"系列A优先股）。指定的A系列优先股数量为70,601。 A系列优先股的面值为每股0.0001美元。

(b) 公司应将A系列优先股在其特定用于此目的的公司过户代理人维护的记录中登记（称为“A优先股登记”），以便随时注明持有人的名义。公司及其过户代理人可能视A系列优先股的登记持有人为绝对股东，用于任何转换以及所有其他目的。A系列优先股只能以记账形式发行。公司或其过户代理人应在持有人将需要转让的A系列优先股交还给公司过户代理人时，在A系列优先股登记中登记对任何A系列优先股的转让。在进行任何此类登记或转让时，应向受让人签发关于已转让A系列优先股股份的新的或记账通知，并向尚未转让的股份签发新的或记账通知。系列A优先股登记其余股份未转让的部分的记账通知

 

2

如果有任何转让，应在三个工作日内发给转让人，本设计规定的条款旨在使所有持有人随时受益，并可由任何持有人强制执行。

第 3. 股息在发行日期后的任何时候，只要A系列优先股股份已发行并尚未清算，A系列优先股持有人应有权获得董事会分红所需的任何资金和合法可用的资产中，每股A系列优先股应有权获得0.0001美元的股息（根据对A系列优先股进行任何股票分红、股票拆分、合并或其他类似的资本重组事件适当调整，在同一日历年内支付普通股以外的任何股票股利）。按照本句之前的规定有权获得A系列优先股股息的权利， 第 3 不累积，并且未因未宣布或支付此类股票股息而给A系列优先股持有人有权获得股息。对A系列优先股持有人支付股息应按照比例分配。除上述优先权利外，A系列优先股持有人有权获得且公司将支付每股A系列优先股 平价 基础上相等的股息。 按常规股票转换 基础上，不考虑此处规定或其他规定，将分红派息以与实际支付给普通股股票相同形式的方式分配给普通股股票（普通股股票分红时，如实际支付给普通股股票的分红与普通股股票的分红相同时（除了普通股股票以补发普通股形式支付的股票分红）。不得向A系列优先股支付其他股息

第 4. 投票权.

（a）未经大多数A系列优先股已发行股份的股东的肯定投票或同意，公司不得对A系列优先股的权力、优先权或权利进行不利改变，也不得修改或修订本《特权、权利和限制说明书》。

（b）除非在 第4（a） 或者根据法律要求，Series A优先股的持有人在任何公司事务上都没有投票权。

第 5. 清算在任何自愿或强制性的清算、解散或清算公司的情况下，包括控制权变更交易，或视为清算事件（任何此类事件，称为“事项”),公司可供分配给股东的资产应在对Series A优先股宣布但尚未支付的任何股息全额支付后，根据持有人持有的股份数，在Series A优先股和普通股的持有人之间按比例分配，为此目的，将所有Series A优先股都视为根据本特权确认书的条款在此种清算前立即转换为普通股，不考虑在此或其他方面规定的任何转换限制，也不考虑转换Series A优先股是否有足够的普通股股份可以用于执行转换。清算 . 在任何自愿或强制性的的清算、解散或公司清算、包括控制权变更交易，或 Deemed Liquidation Event(任何此类事件, 一个“”)，公司资产可用于分配给其股东的分配账户应分发给 Series A优先股和普通股的持有人，比例为每位持有人持有的股份数，本目的是将所有的 Series A优先股视为按照本《特权描述》的条款在这种清算前即时转换为普通股，不考虑此处或其他任何地方设定的转换限制或不考虑股份够不够用以达成转换的情况。

第 6. 转换.

(a) 按持有人选择转换根据所规定的限制条件 第6(d)，根据持有人的选择，每股A系列优先股可转换成若干股普通股，其计算方法为（A）指定价格及所有已宣布但未支付的分红之和除以（B）转换价格，然后向下取整以得到最接近的整股普通股（"普通股转换数量）。在任何按照此条款进行的转换程度上 第6(a) 会使持有人拥有的普通股数量超过根据其发行的股份数量 第6(d) 或者在适用持有人的合理判断中，导致违反1976年《哈特·斯科特·罗迪诺反垄断改进法案》，随时经修订（简称“HSR违规”），则在转换日期，（x）只有可能进行转换而不超过所述限制的A系列优先股份额的那部分 第6(d) 且不导致HSR违规的情况下将被转换为普通股，（y）原本应转换为普通股的剩余A类优先股份将保留为A类优先股。

 

3

(b) 转换机制.

(i) 转换通知持有人应根据 。 通过提供相关转换通知，进行转换 第6(a) 通过提供公司及其过户代理附上的转换通知表格进行 附件A（一个“转换通知已妥当完成并执行。 转换通知必须指定要转换的A系列优先股股数，议题转换前即拥有的A系列优先股股数，以及议题转换而发行的普通股股数。 假设公司的过户代理参与存托公司（DTC’）快速自动化证券转让计划，并且根据证券购买协议第 4.1 节的规定，转换股份可能免除受限制的标签，并且在符合适用证券法的前提下，转换通知可以指定，根据持有人的选择，适用的转换股份是否应当存入持有人通过DTC 的存款提取代理佣金系统（此系统为“DWAC 系统”，任何此类交付都是一个“DWAC交货）。 在没有这样持有人的选择的情况下，此类转换股份将以记账形式存入公司的过户代理处的持有人账户，并应贴有证券购买协议第 4.1 节中规定的受限制标签。 此类转换被视为有效的日期（一个“转换日期“转换日”),应定义为完成并签署的转换通知通过传真或其他电子传输发送，并在公司及其过户代理在正常工作时间内收到，或在转换通知中指定的时间后收到。在转换通知中规定的计算将在明显或数学错误不存在的情况下控制。

(ii) 转换后电子发行交付。转换日期后不迟于标准结算期间包括的交易日数（“股票交付日期）, 公司的过户代理应该（a）在DWAC传递的情况下（如果持有人要求并符合适用证券法和证券购买协议第4.1节的规定），通过在DWAC系统中记入持有人提名的DTC参与者账户电子转移这些转换股份，或者（b）如果正在转换的A类优先股以全球形式发行，符合与DTC的账簿结算，转换股份应通过DTC的账簿转让设施交付给持有人（如果持有人要求并符合适用证券法和证券购买协议第4.1节的规定）。如果在DWAC交付的情况下，这些股份未能在股票交付日期之前以电子方式交付给或按照持有人的指示交付，适用的持有人有权选择通过书面通知公司及其过户代理在或之前随时收到这些股份，如适用，在此情况下，公司的过户代理应立即指示将任何通过DWAC系统交付给持有人的普通股退回，代表转换为公司未能成功转让的A类优先股。 理解并同意转换股份是受限制的证券，应承载证券购买协议第4.1节中规定的限制性标签，但是，有关限制性标签可能根据证券购买协议第4.1(c)节的规定予以撤销。

(iii) 绝对义务. Subject to the Holder’s right to rescind a Notice of Conversion pursuant to 第 6(b)(ii) above, the Corporation’s obligation to issue and deliver the Conversion Shares upon conversion of Series A Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by such Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to such Holder in connection with the issuance of such Conversion Shares. Nothing herein shall limit a Holder’s right to pursue actual damages for the Corporation’s failure to deliver Conversion Shares within the period specified herein and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief; provided that such Holder shall not receive duplicate damages for the Corporation’s failure to deliver Conversion Shares within the period specified herein. The exercise of any such rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.

(iv) Compensation for 买入 on Failure to Timely Deliver Shares Upon Conversion如果公司未能按照规定的股票交割日期进行DWAC交割 第6(b)(i)（除了由于持有人向公司提供的信息不正确或不完整而导致的失败），并且在股票交割日期之后，持有人需要在开放市场上购买

 

4

如果恢复股份交换权利的转换发起人（"持有人"）转让或以其他方式转让公司股票，以交付任何交易日后，转化股份将交付该持有人拥有权利在不受限制的传奇约定的情况下从公司收到的卖出货物的销售满意度满意度日期（"买入），则公司应在该持有人请求后的四个（4）个交易日内，而该持有人自行决定的情况下，（A）支付给该持有人现金（除了该持有人可获得或选择的任何其他补救措施之外）：（x）以上述计划中给出的转化问题的公司股票数量乘以（2）相关的公共股份的公司股票的实际的销售价格（包括任何券商佣金）和（B）按照该持有人的选择，重新发布（如果已经放弃）提交以进行转换或向该持有人提供应发出的公共股数量公司股票，如果公司及时遵守其根据 第的交付要求在6(b)(ii)下.。例如，如果持有人购买总价值为11,000美元的公司股份以应对与企图转换相关的对 买入 进行的持有人的拥有系列A优先股，其中根据通用销售价格（包括任何佣金）产生该购买义务的实际的总价值是前一句（A）总共为10,000美元，公司必须支付给该持有人1,000美元。持有人应在发生 买入，在行使日当天的普通股收盘价的B倍。 指示应付给持有人的金额 有关的 买入 连同由公司合理要求的确认和其他证据。本文件中的任何内容均不限制持有人根据本文件、法律或在权益中可获得其他救济措施的权利，包括但不限于就公司未能按照本协议要求及时交付普通股或 A系列优先股份转换而采取一项具体履行法令和/或临时禁令救济措施；但，提供，持有人不得同时 (i) 要求重新发行未及时兑现的 A系列优先股份而提交转换的股份；以及 (ii) 收到如果公司按照交付要求及时履行其交付要求则应发行的普通股股数 第6(b)(i).

(v) 应付转换而发行的股份保留公司保证将随时保留和保留其已获授权但未发行的普通股份，目的仅为在 A 系列优先股份转换后发行，不受其他人的优先购买权或任何其他实际或潜在购买权限制，高于 A 系列优先股份持有人，以便发行总数量不低于股份总数，此股份应发行的股数（考虑到调整） 第 7在所有未结转的A系列优先股转换之时。这种保留应遵守，而不考虑 第6(d)。公司保证所有应发行的普通股在发行时应当经过充分授权，有效发行，已全额支付 可免评估 并且没有任何抵押和其他负担。

(vi) 碎股。在将A系列优先股转换为普通股时，不得发行普通股的碎股或代表普通股的凭证。所有碎股应向下舍入至最接近的整数普通股。

(vii) 过户税。对于转换股票的电子记账项的发行，不得向任何持有人收取任何文件印花税或类似税项，该税项可能与发行或传递此类电子记账项有关，但公司不必支付可能与转让有关的任何税款，涉及以非注册持有人的名义发行和传递任何此类电子记账项的转换，该公司不需要发行或传递此类电子记账项，除非请求发行该等电子记账项的个人或个人已向公司支付了该税款或已确保公司满意地支付了该税款。

(c) 作为股东的身份。在每个换股日期，A系列优先股转换为普通股时：(i) 转换的A系列优先股应被视为转换为普通股；和 (ii) 持有人作为上述转换的A系列优先股的持有人的权利将终止和终止，仅除了有权收到该等普通股的电子记账项以及因公司未能遵守本权利证明书条款而由本证明书规定或根据法律或平等法规定对此类持有人的任何救济。在所有情况下，持有人应保留对于公司未能转换A系列优先股的所有权利和救济。

 

5

(d) Limitations on Conversion. Except as set forth in this Section 6(d), a Holder shall not have the right to convert any portion of the Series A Preferred Stock or take delivery of shares of Common Stock upon any conversion of shares of Series A Preferred Stock, nor shall the Corporation have any obligation to effect any purported conversion, in each case, to the extent that after giving effect to such conversion, action or delivery, as applicable, such Holder (together with such Holder’s Affiliates, any other Persons acting as a group together, and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder’s and the other Attribution Parties for purposes of Section 13(d) of the Exchange Act (such Persons, “Attribution Parties”)) would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the shares of Common Stock outstanding immediately after giving effect to such conversion. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock held and/or beneficially owned by such Holder and its Attribution Parties shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon conversion of the Series A Preferred Stock with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock which would be issuable upon (i) exercise of the remaining, unconverted portion of the Series A Preferred Stock beneficially owned by such Holder and its Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation beneficially owned by such Holder and its Attribution Parties (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. For purposes of this Section 6(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Corporation’s most recent Form 10-K, Proxy Statement, Form 10-Q, Current Report on Form 8-K or other public filing with the Commission, as the case may be, (2) a more recent public announcement by the Corporation or (3) any other notice by the Corporation or the Corporation’s transfer agent setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the written or oral request of a Holder, where such request indicates that it is being made pursuant to this Section 6(d), the Corporation shall within one (1) Trading Day confirm orally and in writing to such Holder the number of shares of Common Stock then outstanding. The Holder shall disclose to the Corporation the number of shares of Common Stock that it, together with the Attribution Parties holds and/or beneficially owns and has the right to acquire through the conversion of the shares of Series A Preferred Stock and any limitations on conversion analogous to the limitation contained herein contemporaneously or immediately prior to submitting a Notice of Conversion. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including the Series A Preferred Stock, by a Holder and its Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. In the event that the issuance of shares of Common Stock to the Holder upon the conversion of any of such Holder’s shares of Series A Preferred Stock results in the Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock, the number of shares so issued by which such Holder’s and the other Attribution Parties’ aggregate beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”) shall be deemed null and void and shall be cancelled ab initio, and such Holder shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void and/or any other shares of Series A Preferred Stock have been purported to be converted or mandatorily converted in excess of the limitations set forth in this Section 6(d), the Corporation shall return to the Holder the number of shares of Series A Preferred Stock corresponding to such excess. Upon delivery of a written notice to the Corporation, a Holder may from time to time increase or decrease the Maximum Percentage to any other percentage (not in excess of 19.99% of the issued and outstanding Common Stock immediately after giving effect to the issuance of the Common Stock issuable upon conversion of the Series A Preferred Stock if exceeding that limit would result in a change of control under Nasdaq Listing Rule 5635(b) or any successor rule) as specified in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61^st) day after such notice is delivered to the Corporation and (ii) any such increase or decrease will apply only to such Holder and other Attribution Parties and not to any other holder of Series A Preferred Stock, provided, for the avoidance of doubt, that no such decrease shall affect the validity of any prior conversion of the Series A Preferred Stock by a Holder or any Attribution Party. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms hereof in excess of the Maximum Percentage shall not be deemed to be beneficially owned by a Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the Exchange Act. No prior inability to convert Series A Preferred Stock pursuant to this Section 6(d) shall have any effect on the applicability of the provisions of this Section 6(d) with respect to any subsequent determination of whether Series A Preferred Stock may be converted. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 6(d) to the extent necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 6(d) or to make changes or supplements necessary or desirable to properly give effect to such limitation.

 

6

Section 7. Certain Adjustments.

(a) Stock Dividends and Stock Splits. If the Corporation, at any time while any shares of Series A Preferred Stock are outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock with respect to the then outstanding shares of Common Stock; (ii) subdivides outstanding shares of Common Stock into a larger number of shares; or (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event (excluding any treasury shares of the Corporation). Any adjustment made pursuant to this Section 7(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision or combination.

(b) Reclassification, Exchange or Substitution. If the Common Stock issuable upon the conversion of the Series A Preferred Stock shall be changed into the same or a different number of shares of any class or classes of stock, whether by capital reorganization, reclassification, or otherwise (other than a subdivision or combination of shares or stock dividend provided for above, or a reorganization, merger, consolidation, or sale of assets provided for below), then and in each such event the holder of each such share of Series A Preferred Stock shall have the right thereafter to convert such share into the kind and amount of shares of stock and other securities and property receivable, upon such reorganization, reclassification, or other change, by holders of the number of shares of Common Stock into which such shares of Series A Preferred Stock might have been converted immediately prior to such reorganization, reclassification, or change, all subject to further adjustment as provided herein.

(c) Merger or Reorganization, etc. If there shall occur any reorganization, recapitalization, reclassification, consolidation or merger involving the Corporation in which the Common Stock (but not the Series A Preferred Stock) is converted into or exchanged for securities, cash or other property (other than a transaction covered by paragraphs (a) or (b) of this Section 7), then, following any such reorganization, recapitalization, reclassification, consolidation or merger, each share of Series A Preferred Stock shall be convertible into the kind and amount of securities, cash or other property which a holder of the number of shares of Common Stock of the Corporation issuable upon conversion of one share of Series A Preferred Stock immediately prior to such reorganization, recapitalization, reclassification, consolidation or merger would have been entitled to receive pursuant to such transaction (without regard to any limitation in Section 6(d) on the conversion of the Convertible Preferred Stock); and, in such case, appropriate adjustment (as determined in good faith by the Board of Directors) shall be made in the application of the provisions in this Section 7 with respect to the rights and interests thereafter of the holders of the Series A Preferred Stock to the end that the provisions set forth in this Section 7 (including provisions with respect to changes in and other adjustments of the Conversion Price, as applicable) shall thereafter be applicable, as nearly as reasonably may be, in relation to any securities or other property thereafter deliverable upon the conversion of the Series A Preferred Stock.

(d) Calculations. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100^th of a share, as the case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.

(e) Notice to the Holders.

(i) Adjustment to Conversion Price. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the Corporation shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

(ii) Other Notices. If (A) the Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby

 

7

the Common Stock is converted into other securities, cash or property, or (E) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of conversion of the shares of Series A Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the stock books of the Corporation, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distribution, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice; and provided further, that in each case, the Corporation will only be required to provide such information to the Holder if such information shall have be made known to the public prior to or in conjunction with such notice being provided to the Holder.

Section 8. Miscellaneous.

(a) Waiver. Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designations shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designations or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate of Designations on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designations. Any waiver by the Corporation or a Holder must be in writing. Notwithstanding any provision in this Certificate of Designations to the contrary, any provision contained herein and any right of the Holders of Series A Preferred Stock granted hereunder may be waived as to all shares of Series A Preferred Stock (and the Holders thereof) upon the written consent of a majority of shares of Series A Preferred Stock, unless a higher percentage is required by the DGCL, in which case the written consent of the Holders of not less than such higher percentage shall be required.

(b) Severability. If any provision of this Certificate of Designations is invalid, illegal or unenforceable, the balance of this Certificate of Designations shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law.

(c) Next Business Day. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.

(d) Headings. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designations and shall not be deemed to limit or affect any of the provisions hereof.

(e) Status of Converted Series A Preferred Stock. If any shares of Series A Preferred Stock shall be converted into shares of Common Stock pursuant to Section 6 hereof, the Board of Directors shall take such action as is required such that such shares shall resume the status of authorized but unissued shares of preferred stock of the Corporation and shall no longer be designated as Series A Preferred Stock.

********************

 

8

IN WITNESS WHEREOF, Ventyx Biosciences, Inc. has caused this Certificate of Designations of Preferences, Rights and Limitations of Series A Non-Voting Convertible Preferred Stock to be executed by its duly authorized officer this 23^rd day of September, 2024.

 

[SIGNATURE PAGE TO CERTIFICATE OF DESIGNATIONS]

 

9

ANNEX A

NOTICE OF CONVERSION

(TO BE EXECUTED BY THE REGISTERED HOLDER

IN ORDER TO CONVERT SHARES OF SERIES A PREFERRED STOCK)

The undersigned Holder hereby irrevocably elects to convert the number of shares of Series A Preferred Stock indicated below, represented by stock certificate No(s). ____ (the “Preferred Stock Certificates”), into the number of shares of Common Stock of Ventyx Biosciences, Inc., a Delaware corporation (the “Corporation”), equal to the Share Conversion Number, multiplied by the number of shares of Series A Preferred Stock indicated below, provided that, to the extent such conversion would cause such Holder to exceed the Maximum Percentage (as defined in Section 6(d) of the Certificate of Designations), any shares of Series A Preferred Stock convertible into the number of shares of Common Stock that would result in the foregoing exceeding the Maximum Percentage shall not convert into shares of Common Stock and such Holder shall retain any such shares of Series A Preferred Stock. If securities are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto. Capitalized terms utilized but not defined herein shall have the meaning ascribed to such terms in that certain Certificate of Designations of Preferences, Rights and Limitations of Series A Non-Voting Convertible Preferred Stock (the “Certificate of Designations”) filed by the Corporation with the Delaware Secretary of State on September 23, 2024.

The undersigned Holder’s right to convert the shares of Series A Preferred Stock is subject to the Maximum Percentage described in Section 6(d) of the Certificate of Designations. Therefore, the number of shares of Common Stock beneficially owned by the undersigned Holder (together with any Attribution Parties), including the number of shares of Common Stock issuable upon conversion of the Series A Preferred Stock subject to this Notice of Conversion, but excluding (i) exercise of the remaining, unconverted portion of the Series A Preferred Stock beneficially owned by such Person and its Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation beneficially owned by such Person and its Attribution Parties (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein, shall not exceed the Maximum Percentage of the shares of Common Stock outstanding immediately following the effectiveness of this conversion.

Conversion calculations:

Date to Effect Conversion:

Number of shares of Series A Preferred Stock owned immediately prior to Conversion:

Number of shares of Series A Preferred Stock to be Converted:

Number of shares of Common Stock to be Issued:

Address for delivery of physical certificates:

Or

for DWAC Delivery:

DWAC Instructions:

Broker no:

Account no:

 

10

 

Acknowledged and Agreed:

VENTYX BIOSCIENCES, INC.

By:

Name:

Title:

 

11